Literature DB >> 8229843

A possible role for endogenous peripheral corticotrophin-releasing factor-41 in the febrile response of conscious rabbits.

N G Milton1, E W Hillhouse, A S Milton.   

Abstract

1. The actions of peripheral corticotrophin-releasing factor-41 (CRF-41) on the febrile responses of conscious rabbits induced by peripherally administered polyinosinic.polycytidylic acid (poly(I).poly(C)) have been studied using a CRF-41 receptor antagonist (alpha-helical CRF(9-41) and anti-CRF-41 monoclonal antibodies. 2. Temperature responses were monitored continuously using rectal thermistor probes. Test substances were administered intravenously (i.v.), or for central CRF-41 antagonism experiments, via an indwelling third ventricle cannula (I.C.V.). Blood samples were taken at time intervals from a marginal ear vein and plasma cortisol levels determined by radioimmunoassay. 3. Poly(I).poly(C) (2.5 micrograms/kg) stimulated a reproducible biphasic rise in body temperature with a lag phase of 45-60 min and peaks at 90 and 225 min. 4. The febrile response to poly(I).poly(C) (2.5 micrograms/kg I.V.) was antagonized by blockade of peripheral CRF-41 actions using either monoclonal anti-CRF-41 antibodies (2.5 mg/kg i.v.) or the CRF-41 receptor antagonist (alpha-helical CRF(9-41); 25 micrograms/kg i.v.) administered 5 min prior to the pyrogen. 5. Centrally administered CRF-41 receptor antagonist (2.5 micrograms/kg I.C.V.) failed to affect the febrile response to poly(I).poly(C) (2.5 micrograms/kg i.v.). 6. CRF-41 immunoneutralization after the onset of temperature rises caused an immediate and significant defervescence. 7. In conclusion, these results suggest a modulatory pro-pyretic role for endogenous peripheral CRF-41 in the febrile responses to poly(I).poly(C).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8229843      PMCID: PMC1175437          DOI: 10.1113/jphysiol.1993.sp019684

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  32 in total

1.  Studies with radioactive endotoxin. I. The use of Cr51 to label endotoxin of Escherichia coli.

Authors:  A I BRAUDE; F J CAREY; D SUTHERLAND; M ZALESKY
Journal:  J Clin Invest       Date:  1955-06       Impact factor: 14.808

2.  Central activation of thermogenesis by prostaglandins: dependence on CRF.

Authors:  N J Rothwell
Journal:  Horm Metab Res       Date:  1990-12       Impact factor: 2.936

Review 3.  A critical assessment of the interactions between the immune system and the hypothalamo-pituitary-adrenal axis.

Authors:  R Buzzetti; L McLoughlin; D Scavo; L H Rees
Journal:  J Endocrinol       Date:  1989-02       Impact factor: 4.286

Review 4.  Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor.

Authors:  F A Antoni
Journal:  Endocr Rev       Date:  1986-11       Impact factor: 19.871

5.  Stimulatory effect of corticotropin-releasing neurohormone on human lymphocyte proliferation and interleukin-2 receptor expression.

Authors:  V K Singh
Journal:  J Neuroimmunol       Date:  1989-08       Impact factor: 3.478

6.  Synthetic competitive antagonists of corticotropin-releasing factor: effect on ACTH secretion in the rat.

Authors:  J Rivier; C Rivier; W Vale
Journal:  Science       Date:  1984-05-25       Impact factor: 47.728

7.  Antipyretic effect of centrally administered CRF.

Authors:  G L Bernardini; D B Richards; J M Lipton
Journal:  Peptides       Date:  1984 Jan-Feb       Impact factor: 3.750

8.  Corticotropin-releasing factor (CRF): central effects on mean arterial pressure and heart rate in rats.

Authors:  L A Fisher; J Rivier; C Rivier; J Spiess; W Vale; M R Brown
Journal:  Endocrinology       Date:  1982-06       Impact factor: 4.736

9.  The pyrogenic actions of the interferon-inducer, polyinosinic:polycytidylic acid are antagonised by ketoprofen.

Authors:  D Rotondo; H T Abul; A S Milton; J Davidson
Journal:  Eur J Pharmacol       Date:  1987-06-04       Impact factor: 4.432

10.  Effects on body temperature of prostaglandins of the A, E and F series on injection into the third ventricle of unanaesthetized cats and rabbits.

Authors:  A S Milton; S Wendlandt
Journal:  J Physiol       Date:  1971-10       Impact factor: 5.182

View more
  4 in total

1.  Does endogenous peripheral arginine vasopressin have a role in the febrile responses of conscious rabbits?

Authors:  N G Milton; E W Hillhouse; A S Milton
Journal:  J Physiol       Date:  1993-09       Impact factor: 5.182

2.  Immunolocalization of Kisspeptin Associated with Amyloid-β Deposits in the Pons of an Alzheimer's Disease Patient.

Authors:  Amrutha Chilumuri; Maria Ashioti; Amanda N Nercessian; Nathaniel G N Milton
Journal:  J Neurodegener Dis       Date:  2013-05-16

3.  PKR deficiency alters E. coli-induced sickness behaviors but does not exacerbate neuroimmune responses or bacterial load.

Authors:  David Chun-Hei Poon; Yuen-Shan Ho; Ran You; Hei-Long Tse; Kin Chiu; Raymond Chuen-Chung Chang
Journal:  J Neuroinflammation       Date:  2015-11-19       Impact factor: 8.322

Review 4.  Central mediators involved in the febrile response: effects of antipyretic drugs.

Authors:  Aleksander R Zampronio; Denis M Soares; Glória E P Souza
Journal:  Temperature (Austin)       Date:  2015-10-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.